Stop Patient Enrollment in Avigan Studies: Drug Damage Watchdog

July 3, 2020
Medwatcher Japan, a citizen’s drug damage watchdog, issued a statement on July 2 calling for suspending new patient enrollments in investigator-led studies to test Fujifilm’s antiviral agent Avigan (favipiravir) for the treatment of COVID-19. In a large observational study being...read more